Whereas in our study, the use of cells expressing receptors containing site-specific point mutations impeded the binding of endogenous skelemin but not the interactions of other cellular proteins with the integrin tails.
Therefore endogenous presentation of the MMP-2 antigen can be induced by mutations impeding the formation of one disulfide bond within MMP-2 propeptide or fibronectin domain.
In vivo studies have also demonstrated that APC loss or mutation impedes enterocyte migration along the crypt-villus axis [ 34, 35] and forced overexpression of APC results in disordered, non-adhesive intestinal cell migration, presumably by changing the relative activity of cadherin-catenin complexes [ 36].
These results suggest that the A530V mutation impedes PHD2-mediated hydroxylation of P531, which negatively impacts HIF-2α binding affinity for pVHL.
A very convenient feature of fosfomycin, among others, is that although the expected frequency of resistant mutants is high, the biological cost associated with mutation impedes an effective growth rate, and bacteria cannot offset the obstacles posed by host defenses or compete with sensitive bacteria.
Instead, the y11-2 mayatimpedey impede the integration of the mutant ChlI1a protein into the hexameric ring and thus the mutant ChlI protein cannot inhibit the function of wild-type ChlI1a and ChlI1b proteins (see wild-type/ y11-2 and y11-2/y11-2 in Figure 6A).
The occurrence of such a mutation can impede the effectiveness of anti-EGFR therapeutics such as cetuximab.
Thus, the CUL3Δ403 459 mutation is a novel physiological example of the importance of this CRL rigidity and to our knowledge the first example of a human mutation that impedes the scaffolding function of a Cullin.
We have also shown that the T9176G mutation severely impedes the incorporation of the protein encoded by the ATP6 gene (which is referred to as subunit a or subunit 6) into yeast ATP synthase (Kucharczyk et al., 2009b), and evidence for similar defects has been reported in skin fibroblasts from patients carrying this mutation (Carrozzo et al., 2001).
This occurs when the flow of electrons out of at least one of the chains is blocked, or severely inhibited, as for example in the presence of inhibitor antimycin which blocks the outflow of electrons from the b-chain [9,10], or in the presence of the heme c1 knockout mutation which impedes the electron outflow from the c-chain mimicking the conditions of hypoxia [11].
